Skip to main content
Log in

New iridium bis‐terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials

  • Published:
BioMetals Aims and scope Submit manuscript

Abstract

This study represents synthesis, characterization, screening of antibiofilm efficacy, and cytotoxicity of iridium bis-terpyridine complexes. The complexes were characterized by NMR, MS, FTIR, UV/Visible, and fluorescence spectroscopies. The efficacy of biofilm inhibition and eradication of iridium complexes was evaluated using a crystal violet assay test and verified by fluorescence microscopy. Cytotoxicity and apoptosis analysis of iridium complexes were determined in this study. The results of our study revealed that three iridium complexes had the potential to inhibit biofilm formation and moderate the ability to destroy pre-formed biofilm of S. aureus ATCC 29,213. 250 µM concentration of synthesized complexes showed the highest antibiofilm activity (75% for Ir1, 90% for Ir2, and 71% for Ir3). The significant inhibition obtained at 6.25 µM concentration of Ir2 and Ir3 revealed the potential of our samples. Also, Ir1 and Ir2 complexes had a good capacity to destroy pre-formed biofilm. The results clearly showed that iridium complexes have cytotoxic activity towards colon cancer (Caco-2) and liver cancer (HepG2) cell lines without affecting non-cancerous cells (HEK293) at applied doses. Moreover, tested compounds induced apoptosis in these cancer cells. All of these results showed that iridium complexes had possessed the ability to inhibit or destroy pre-formed biofilm and could be developed as an effective agent against bacterial biofilms. Moreover, these pure substances may have valuable anti-cancer activity and it should be confirmed with further studies for therapeutic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

Download references

Acknowledgements

S. A., C. S. and N. M. D. thank to Pamukkale University (PAU-BAP-2018-KRM-011 for the cytotoxicity and apoptosis studies, PAU-BAP-2020KRM005-016 for synthesis of iridium complexes, and PAU-BAP-2020KRM005-020 for antibiofilm studies). The synthesis of terpyridines ligands part of this paper has been supported by the RUDN University Strategic Academic Leadership Program.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Cigdem Sahin, Ghodrat Mahmoudi or Sevki Arslan.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 879 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahin, C., Mutlu, D., Nasirli, F. et al. New iridium bis‐terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials. Biometals 34, 701–713 (2021). https://doi.org/10.1007/s10534-021-00307-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10534-021-00307-y

Keywords

Navigation